Flyte has secured a strategic minority investment from Catheter Precision, with Catheter acquiring 19.98% equity ownership in the company. The minority investment ensures Flyte retains strategic and operational control of the company.

The investment enables scalable growth of the Flyte’s Vision Jet platform, supported by AI-driven optimisation across routing, pricing, dispatch and utilisation and long-term monetisation flexibility.

Marc Sellouk, CEO and founder of Flyte, says: “Flyte is operating today with certified aircraft, established routes and scalable infrastructure. Our model is rooted in disciplined execution, capital efficiency and measured growth, positioning us for the long-term evolution of regional air mobility. Demand for premium short-haul connectivity is accelerating, and Flyte is purpose-built for this moment, combining real operations, real infrastructure and a scalable fleet strategy focused on execution and long-term value creation.”

Flyte operates today in the same short-haul regional corridors targeted by future electric aircraft developers, generating operating data, route density and customer engagement using certified aircraft and established regulatory infrastructure.